Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study

被引:1
|
作者
Savulescu, Camelia [1 ]
Krizova, Pavla [2 ]
Lepoutre, Agnes [3 ]
Mereckiene, Jolita [4 ]
Vestrheim, Didrik F. [5 ]
Ciruela, Pilar [6 ,9 ]
Ordobas, Maria [7 ]
Guevara, Marcela [8 ,9 ]
McDonald, Eisin [10 ]
Morfeldt, Eva [11 ]
Kozakova, Jana [2 ]
Varon, Emmanuelle [12 ]
Cotter, Suzanne [4 ]
Winje, Brita A. [5 ]
Munoz-Almagro, Carmen [9 ,13 ,14 ]
Garcia, Luis [7 ]
Castilla, Jesus [8 ,9 ]
Smith, Andrew [15 ]
Henriques-Normark, Birgitta [11 ,16 ,17 ]
Celentano, Lucia Pastore [18 ]
Hanquet, Germaine [1 ]
机构
[1] EpiConcept, Epidemiol Dept, 47 Rue Charenton, F-75012 Paris, France
[2] Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Prague, Czech Republic
[3] French Natl Agcy Publ Hlth, Infect Dis Dept, St Maurice, France
[4] Hlth Protect Surveillance Ctr, Vaccine Preventable Dis Dept, Dublin, Ireland
[5] Norwegian Inst Publ Hlth, Dept Vaccine Preventable Dis, Oslo, Norway
[6] Publ Hlth Agcy Catalunya, Gen Sub Directorate Surveillance & Publ Hlth Emer, Barcelona, Spain
[7] Sub Directorate Hlth Promot & Prevent, Madrid, Spain
[8] Publ Hlth Inst Navarra IdiSNA, Pamplona, Spain
[9] CIBER Epidemiol & Salud Publ, Madrid, Spain
[10] Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland
[11] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden
[12] European Hosp George Pompidou, Natl Ctr Pneumococci, Paris, France
[13] Hosp San Juan Dios, Mol Microbiol Dept, Barcelona, Spain
[14] Univ Int Catalunya, Barcelona, Spain
[15] Meningococcus & Pneumococcus Reference Lab, Legionella, Scottish Haemophilus, Glasgow, Lanark, Scotland
[16] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden
[17] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden
[18] European Ctr Dis Prevent & Control, Off Chief Sci Unit, Stockholm, Sweden
来源
LANCET RESPIRATORY MEDICINE | 2017年 / 5卷 / 08期
关键词
SEROTYPE REPLACEMENT; IMPACT; VACCINATION; SURVEILLANCE; 7-VALENT; ENGLAND; COHORT; QUEBEC; CANADA; ADULTS;
D O I
10.1016/S2213-2600(17)30110-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors populations in nine sites in seven European countries for invasive pneumococcal disease. Five sites use 13-valent pneumococcal conjugate vaccine (PCV13) alone and four use the ten-valent PCV (PCV10) and PCV13. Vaccination uptake is greater than 90% in six sites and 67-78% in three sites. We measured the effects of introducing high-valency PCVs on the incidence of invasive pneumococcal disease in children younger than 5 years. Methods We compared the incidence of invasive pneumococcal disease in each of the 4 years after the introduction of PCV13 alone or PCV10 and PCV13 with the average incidence during the preceding period of heptavalent PCV (PCV7) use, overall and by serotype category. We calculated incidence rate ratios (IRRs) and 95% CIs for each year and pooled the values for all sites in a random effects meta-analysis. Findings 4 years after the introduction of PCV13 alone or PCV10 and PCV13, the pooled IRR was 0.53 (95% CI 0.43-0.65) for invasive pneumococcal disease in children younger than 5 years caused by any serotype, 0.16 (0.07-0.40) for disease caused by PCV7 serotypes, 0.17 (0.07-0.42) for disease caused by 1, 5, and 7F serotypes, and 0.41 (0.25-0.69) for that caused by 3, 6A and 19A serotypes. We saw a similar pattern when we restricted the analysis to sites where only PCV13 was used. The pooled IRR for invasive pneumococcal disease caused by non-PCV13 serotypes was 1.62 (1.09-2.42). Interpretation The incidence of invasive pneumococcal disease caused by all serotypes decreased due to a decline in the incidence of vaccine serotypes. By contrast, that of invasive pneumococcal disease caused by non-PCV13 serotypes increased, which suggests serotype replacement. Long-term surveillance will be crucial to monitor the further effects of PCV10 and PCV13 vaccination programmes in young children.
引用
收藏
页码:648 / 656
页数:9
相关论文
共 50 条
  • [31] Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
    Ladhani, Shamez N.
    Slack, Mary P. E.
    Andrews, Nick J.
    Waight, Pauline A.
    Borrow, Ray
    Miller, Elizabeth
    [J]. EMERGING INFECTIOUS DISEASES, 2013, 19 (01) : 61 - 68
  • [32] Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine
    Abuelreish, Motasem
    Subedar, Asad
    Chiu, Thomas
    Wludyka, Peter
    Rathore, Mobeen
    [J]. CLINICAL PEDIATRICS, 2007, 46 (01) : 45 - 52
  • [33] Serotype Coverage of Invasive and Mucosal Pneumococcal Disease in Israeli Children Younger Than 3 Years by Various Pneumococcal Conjugate Vaccines
    Shouval, Dror S.
    Greenberg, David
    Givon-Lavi, Noga
    Porat, Nurith
    Dagan, Ron
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : 277 - 282
  • [34] Epidemiology of Invasive Pneumococcal Disease in Bangladeshi Children Before Introduction of Pneumococcal Conjugate Vaccine
    Saha, Samir K.
    Hossain, Belal
    Islam, Maksuda
    Hasanuzzaman, Md
    Saha, Shampa
    Hasan, Mohammad
    Darmstadt, Gary L.
    Chowdury, Mrittika
    El Arifeen, Shams
    Baqui, Abdullah H.
    Breiman, Robert F.
    Santosham, Mathuram
    Luby, Stephen P.
    Whitney, Cynthia G.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (06) : 655 - 661
  • [35] Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease
    Kim, Young Keun
    Lafon, David
    Nahm, Moon H.
    [J]. INFECTION AND CHEMOTHERAPY, 2016, 48 (04): : 257 - 266
  • [36] Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
    Simon Rückinger
    Mark van der Linden
    Rüdiger von Kries
    [J]. BMC Infectious Diseases, 10
  • [37] Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
    Rueckinger, Simon
    van der Linden, Mark
    von Kries, Ruediger
    [J]. BMC INFECTIOUS DISEASES, 2010, 10
  • [38] Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review
    Ngocho, James Samwel
    Magoma, Best
    Olomi, Gaudencia Alois
    Mahande, Michael Johnson
    Msuya, Sia Emmanueli
    de Jonge, Marien Isaak
    Mmbaga, Blandina Theophil
    [J]. PLOS ONE, 2019, 14 (02):
  • [39] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    [J]. EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [40] METHOD OF PREDICTING SEROTYPE SPECIFIC EFFECTIVENESS AGAINST INVASIVE PNEUMOCOCCAL DISEASE FOR PNEUMOCOCCAL CONJUGATE VACCINES IN INFANT POPULATION
    Ryman, J.
    Yee, K. L.
    Weaver, J.
    Hu, T.
    Sachs, J.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S205 - S205